Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma

NCT02541903 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped poor overall accrual

Conditions

Penile Squamous Cell Carcinoma (PSCC)

Interventions

DRUG: Gilotrif

Sponsor

University of Alabama at Birmingham